SOC Teinture de baies de sureau du Canada
SOC Teinture de baies de sureau du Canada, NPN 80074582: natural health product licensed in Canada. Medicinal ingredients: Sambucus nigra subsp. canadensis.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sambucus nigra subsp. canadensis Source : Fruit Extract : Matériel brut sec Extraction ratio : 1:10 Dry plant equivalent : 0.1 Grammes | 1 millilitre | Not calculated |
Non-medicinal ingredients
Alcool, sucre, Eau
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Cuillère à thé | 3 Tous les jours |
Uses authorised in Canada
Utilisé en phytothérapie pour induire la sudation (diaphorétique), pour aider à soulager la fièvre (dans les cas de rhume, ou de grippe); Utilisé en phytothérapie pour aider à soulager les symptômes du rhume et de la grippe (tels que la toux, le mal de gorge et les catarrhes des voies respiratoires supérieures).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Known Adverse Reactions
Une hypersensibilité (une allergie) peut se manifester; dans le cas, cessez l'utilisation. Cesser l'usage en cas de problèmes gastro-intestinaux tels que des crampes abdominales, des nausées, des vomissements ou de la diarrhée. Un effet diurétique pourrait se produire.
- Cautions and Warnings
Si les symptômes s'aggravent ou persistent, consulter un practitien de soins de santé; Ne pas utiliser si vous êtes enceinte ou si vous allaitez.
Product record
- Licence holder
- 4XL Distribution
- NPN or DIN-HM
- 80074582
- Status
- Active licence
- Licence date
- 19 December 2016
- Revision date
- Not provided
- Form
- Liquide oral
- Route of administration
- Orale
- Application type
- Officinale
Source
Official Health Canada record, licence 80074582
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Sambucus nigra subsp. canadensis
Read the warning, when it applies and the studies cited
ELDER – SAMBUCUS
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Condition of application: Diaphoretic; Symptoms of colds, flus; Sinusitis, hay-fever; Joint pain.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Known adverse reactions
Condition of application: All products.
Stop use if hypersensitivity/allergy occur (Forster-Waldl et al. 2003).
Sources cited by Health Canada (1)
- Förster-Waldl E, Marchetii M, Schöll I, Focke M, Radauer C, Kinaciyan T, Nentwich I, Jäger S, Schmid ER, Boltz-Nitulescu G, Scheiner O, Jensen-Jarolim E. Type I allergy to elderberry (Sambucus nigra) is elicited by a 33.2 kDa allergen with significant homology to ribosomal inactivating proteins. Clinical and Experimental Allergy 2003;33(2):1703-1710. PubMed
Condition of application: All products except those making a diuretic claim.
When using this product diuretic effect may occur (Bradley 1992; Winston and Kuhn 2008; Barnes et al. 2007; Hoffman 2003).
Sources cited by Health Canada (2)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines. 3rd edition. London (GB): The Pharmaceutical Press; 2007.
- Winston D and Kuhn MA. Herbal Therapy & Supplements A Scientific and Traditional Approach. Philadelphia (PA): Lippincott Williams & Wilkins; 2008.
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “SOC Teinture de baies de sureau du Canada (4XL Distribution): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80074582-soc-teinture-de-baies-de-sureau-du-canada, updated 19 December 2016.